22nd May 2019 – An autoinjector is a device designed to drop a dose of a specific drug. Some of the autoinjectors are spring-loaded syringes. Auto injectors are alternative to manual syringe injections for subcutaneous administration of drugs. The devices allow the patient to self-inject for diagnosis. Patients with a chronic history of autoimmune disorders and multiple scelerosis are known to have using auto injectors. Technically, auto injector devices are auto injector pens having a push switch at the top with a closure.
Global auto-injector market is anticipated to grow at a significant CAGR during the forecast period.
Auto injector market is driven by rise in prevalence of targeted therapies such as multiple scelerosis, rheumatoid arthritis and higher incidence of anaphylaxis. In addition, availability of various auto-injector devices for better route of drug administration is supplementing the market growth. High risks associated with conventional syringes coupled with discontinuation of drugs also propels the market growth. Patient compliance, demand for biologics, rise in number of diabetic patients and growth in cancer cases are more likely to enlarge the market demand. However, regulatory approvals, injuries, infections and mortality rate hinder the market growth during the forecast period.
Read Complete Report With TOC @ https://www.millioninsights.com/industry-reports/auto-injector-market
Product segmentation for auto injector market comprises fillable and prefilled auto injectors. By technology, the market entails automated and manual auto injectors. By design, the market is bifurcated into standardized and customized. Usability segment for auto-injector industry comprises reusable and disposable auto injectors.
Geographical segmentation for the market comprises North America, South America, Europe, Asia-Pacific, Middle East and Africa. North America dominates the global market owing to presence of medical infrastructure, FDA approvals and rise in prevalence of anaphylaxis. Increasing prevalence of autoimmune and chronic disease in US are triggering the regional market growth.
Asia-Pacific regions are rising at a higher CAGR due to rising incidences of autoimmune disorders, availability of medical infrastructure and significance of technological developments in the region. The key players profiled in auto-injector market report are Amgen, Abbvie, Biogen, Eli Lilly, Merck, J&J, Novartis, Bayer, Ypsomed, Becton, Dickinson & Company, Owen Mumford and Haselmeier.
Get a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/auto-injector-market/request-sample